CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma

  • Lidia Giraudo
  • , Giulia Cattaneo*
  • , Loretta Gammaitoni
  • , Ilenia Iaia
  • , Chiara Donini
  • , Annamaria Massa
  • , Maria Laura Centomo
  • , Marco Basiricò
  • , Elisa Vigna
  • , Alberto Pisacane
  • , Franco Picciotto
  • , Enrico Berrino
  • , Caterina Marchiò
  • , Alessandra Merlini
  • , Luca Paruzzo
  • , Stefano Poletto
  • , Daniela Caravelli
  • , Andrea Michela Biolato
  • , Valentina Bortolot
  • , Elisa Landoni
    • Marco Ventin, Cristina R. Ferrone, Massimo Aglietta, Gianpietro Dotti, Valeria Leuci, Fabrizio Carnevale-Schianca, Dario Sangiolo*
*Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review

8 Citations (Scopus)

Fingerprint

Dive into the research topics of 'CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology

Keyphrases